Dynavax Technologies
Biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Launch date
Employees
Market cap
AUD2.2b
Enterprise valuation
AUD1.5b (Public information from Sep 2024)
Share price
$11.5 DVAX
Berkeley California (HQ)
Authorizing premium user...